11.08.2016 • News

Philippe Saudan Chief Development Officer at Kuros

Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology
from the University of Lausanne, Switzerland, and a 16 year-career in the pharmaceutical industry, Saudan has held management roles in R&D and last served as Chief Scientific Officer of Cytos Biotechnology. Since February 2016, he has been working as Head of Integration at Kuros.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.